-Mayumi Shibuya Researcher Activity Profile

Research Author Detailed Information 

Mayumi Shibuya Publication Rate By Year

Mayumi Shibuya has published 1 paper(s) in 1978, 1 paper(s) in 1979, 2 paper(s) in 1983, 2 paper(s) in 1985, 1 paper(s) in 1986, 1 paper(s) in 1987, 1 paper(s) in 1992, 1 paper(s) in 1995, 1 paper(s) in 1996, 2 paper(s) in 2004, 2 paper(s) in 2006, 22 paper(s) in 2007, 8 paper(s) in 2008, for a total of 45 research publications in total.

Mayumi M Shibuya Author Information

LAST NAME: shibuya

FIRST NAME: Mayumi

INITIALS: m

AFFILIATION:

Papers

Mayumi Shibuya's Publication Record

1. A diacylglycerol kinase modulates long-term thermotactic behavioral plasticity in C. elegans. Year Published: 2006
Department of Physics, Harvard University, 17 Oxford Street, Cambridge, Massachusetts 02138, USA.
2. [Clinical features of lung cancer HIV-infected patients] Year Published: 2007
Department of Respiratory Medicine, Tokyo Metropolitan Komagome Hospital.
3. Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. Year Published: 2007
Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute and Helsinki University Hospital, Biomedicum Helsinki, University of Helsinki, 00014 Helsinki, Finland.
4. Activation of phosphatidylinositol 3-kinase/protein kinase B pathway by a vanadyl compound mediates its neuroprotective effect in mouse brain ischemia. Year Published: 2007
Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aramaki-Aoba Aoba-ku, Sendai 980-8578, Japan.
5. Hepatocyte growth factor significantly suppresses collagen-induced arthritis in mice. Year Published: 2007
Department of Allergy and Rheumatology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
6. Direct One-Pot Synthesis of alpha-Siloxy-Weinreb Amides from Aldehydes. Year Published: 2007
Department of Pharmaceutical Chemistry, Division of Health Biosciences, Graduate School of The University of Tokushima, 1-78-1, Tokushima, Japan 770-8505 nem@ph.tokushima-u.ac.jp.
7. [Clinical features of lung cancer HIV-infected patients] Year Published: 2007
Department of Respiratory Medicine, Tokyo Metropolitan Komagome Hospital.
8. Gemcitabine resistance in a highly metastatic subpopulation of a pulmonary adenocarcinoma cell line resistant to gefitinib. Year Published: 2007
Department of Internal Medicine, Division of Pulmonary Medicine, Infectious Diseases and Oncology, Nippon Medical School, Tokyo 113-8602, Japan.
9. The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3. Year Published: 2007
Laboratory of Molecular Medicine, Human Genome Center, The University of Tokyo, Tokyo, Japan.
10. A new extragenic suppressor of cya mutation. Mutant cyclic AMP receptor protein with an increased affinity for cyclic AMP. Year Published: 1978
11. Studies on stringent control in a cell-free system. Regulation by guanosine-5'-diphosphate-3'-diphosphate of the synthesis of elongation factor Tu. Year Published: 1979
12. Effect of pyridoxine-deficiency on the syntheses of aspartate aminotransferase in rat liver and muscle in vivo. Year Published: 1983
13. Effect of pyridoxine deficiency on activities and amounts of aspartate aminotransferase isozymes in rat tissues. Year Published: 1983
14. Effect of pyridoxine-deficiency on the turnover of aspartate aminotransferase isozymes in rat liver. Year Published: 1986
15. Gemcitabine resistance in a highly metastatic subpopulation of a pulmonary adenocarcinoma cell line resistant to gefitinib. Year Published: 2007
Department of Internal Medicine, Division of Pulmonary Medicine, Infectious Diseases and Oncology, Nippon Medical School, Tokyo, Japan.
16. Ligand-independent activation of vascular endothelial growth factor receptor 1 by low-density lipoprotein. Year Published: 2007
Department of Pharmacology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.
17. A case of 'lymphomatosis cerebri' diagnosed in an early phase and treated by whole brain radiation: case report and literature review. Year Published: 2007
Department of Neurosurgery, Shizuoka City Shimizu Hospital, Shizuoka, Japan, ryuichi@kj9.so-net.ne.jp.
18. The cellular and behavioral consequences of interleukin-1 alpha penetration through the blood-brain barrier of neonatal rats: A critical period for efficacy. Year Published: 2007
Division of Molecular Neurobiology, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
19. [Clinical features of lung cancer HIV-infected patients] Year Published: 2007
Department of Respiratory Medicine, Tokyo Metropolitan Komagome Hospital.
20. Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. Year Published: 2007
Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute and Helsinki University Hospital, Biomedicum Helsinki, University of Helsinki, 00014 Helsinki, Finland.
21. Activation of phosphatidylinositol 3-kinase/protein kinase B pathway by a vanadyl compound mediates its neuroprotective effect in mouse brain ischemia. Year Published: 2007
Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aramaki-Aoba Aoba-ku, Sendai 980-8578, Japan.
22. Direct one-pot synthesis of alpha-siloxy-Weinreb amides from aldehydes. Year Published: 2007
Department of Pharmaceutical Chemistry, Division of Health Biosciences, Graduate School of The University of Tokushima, 1-78-1, Tokushima, Japan 770-8505. nem@ph.tokushima-u.ac.jp
23. Gemcitabine resistance in a highly metastatic subpopulation of a pulmonary adenocarcinoma cell line resistant to gefitinib. Year Published: 2007
Department of Internal Medicine, Division of Pulmonary Medicine, Infectious Diseases and Oncology, Nippon Medical School, Tokyo, Japan.
24. Ligand-independent activation of vascular endothelial growth factor receptor 1 by low-density lipoprotein. Year Published: 2007
Department of Pharmacology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.
25. Enzymatic cyclization of 22,23-dihydro-2,3-oxidosqualene into euph-7-en-3beta-ol and bacchar-12-en-3beta-ol by recombinant beta-amyrin synthase. Year Published: 2004
School of Pharmaceutical Sciences and the COE 21 Program, University of Shizuoka, Shizuoka 422-8526, Japan.
26. Mechanism and stereochemistry of enzymatic cyclization of 24,30-Bisnor-2,3-oxidosqualene by recombinant beta-amyrin synthase. Year Published: 2004
School of Pharmaceutical Sciences and the COE 21 Program, University of Shizuoka, Shizuoka 422-8526, Japan. abei@ys7.u-shizuoka-ken.ac.jp
27. 2-azaadamantane N-oxyl (AZADO) and 1-Me-AZADO: highly efficient organocatalysts for oxidation of alcohols. Year Published: 2006
Department of Organic Chemistry and Biophysical Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Aobayama, Sendai 980-8578, Japan.
28. Squalene cyclase and oxidosqualene cyclase from a fern. Year Published: 2008
Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
29. [Programmed learning for the development of the art of nursing] Year Published: 1985
30. [Programmed learning for the development of the art of nursing] Year Published: 1985
31. Ultrastructural pathology of the middle ear mucosa in otitis media with effusion. Year Published: 1987
Department of Otolaryngology, Tohoku University School of Medicine, Sendai, Japan.
32. A case of 'lymphomatosis cerebri' diagnosed in an early phase and treated by whole brain radiation: case report and literature review. Year Published: 2007
Department of Neurosurgery, Shizuoka City Shimizu Hospital, Shizuoka, Japan. ryuichi@kj9.so-net.ne.jp
33. The cellular and behavioral consequences of interleukin-1 alpha penetration through the blood-brain barrier of neonatal rats: a critical period for efficacy. Year Published: 2007
Division of Molecular Neurobiology, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
34. [Transaortic repair of aortopulmonary septal defect in neonate (20 days of age, 2175 gram) using profoundly hypothermic circulatory arrest] Year Published: 1992
Division of Cardiovascular Surgery, Sakakibara Heart Institute, Tokyo, Japan.
35. [Relation between preoperative ventricular arrhythmias and postoperative results in aortic valve regurgitation] Year Published: 1995
Department of Cardiovascular Surgery, Heart Institute of Japan, Tokyo Women's Medical College.
36. [Cardiac surgery in patients on chronic hemodialysis] Year Published: 1996
Department of Cardiovascular Surgery, Heart Institute of Japan, Tokyo Women's Medical College, Japan.
37. Anti-tumor activity and tumor vessel normalization by the vascular endothelial growth factor receptor tyrosine kinase inhibitor KRN951 in a rat peritoneal disseminated tumor model. Year Published: 2008
Development Research Laboratories, Kirin Pharma, 3 Miyahara, Takasaki, Gunma 370-1295, Japan. e-taguchi@kirin.co.jp
38. [A case of caffeine poisoning, survived by percutaneous cardio-pulmonary support] Year Published: 2008
Department of Traumatology and Critical Care Medicine, Matsudo Municipal Hospital.
39. Direct one-pot synthesis of alpha-siloxy-Weinreb amides from aldehydes. Year Published: 2007
Department of Pharmaceutical Chemistry, Division of Health Biosciences, Graduate School of The University of Tokushima, 1-78-1, Tokushima, Japan 770-8505. nem@ph.tokushima-u.ac.jp
40. Regulation of clathrin-mediated endocytosis by p53. Year Published: 2008
Radiobiology Division, National Cancer Center Research Institute, Tokyo, Japan.
41. The cellular and behavioral consequences of interleukin-1 alpha penetration through the blood-brain barrier of neonatal rats: a critical period for efficacy. Year Published: 2007
Division of Molecular Neurobiology, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
42. Spectroscopic observations of beam and source plasma light and testing Cs-deposition monitor in the large area negative ion source for LHD-NBI. Year Published: 2008
National Institute for Fusion Science, Toki, Gifu, Japan. oka@lhd.nifs.ac.jp
43. Neutral beam injection with an improved accelerator for LHD. Year Published: 2008
National Institute for Fusion Science, Gifu, Japan. tsumori@nifs.ac.jp
44. Squalene cyclase and oxidosqualene cyclase from a fern. Year Published: 2008
Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.
45. Novel characteristics of community-acquired methicillin-resistant Staphylococcus aureus strains belonging to multilocus sequence type 59 in Taiwan. Year Published: 2008
Division of Bacteriology, Department of Infectious Disease Control and International Medicine, Niigata University Graduate School of Medical and Dental Sciences, 757 Ichibanchou, Asahimachidori, Niigata, Japan.